The correlation between lung function parameters, and level of activity in seropositive rheumatoid arthritis

G. Apti, A. Trailescu (Constanta, Bucharest, Romania)

Source: Annual Congress 2011 - Lung function today and tomorrow II
Session: Lung function today and tomorrow II
Session type: Thematic Poster Session
Number: 1213
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Apti, A. Trailescu (Constanta, Bucharest, Romania). The correlation between lung function parameters, and level of activity in seropositive rheumatoid arthritis. Eur Respir J 2011; 38: Suppl. 55, 1213

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009


Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA)
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019


The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008


Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006

Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019



Altered exhaled NO parameters in newly onset of rheumatoid arthritis
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020


The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA)
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Characteristics and predictors of outcome in rheumatoid arthritis related ILD
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008



The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA)
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006

Drug-induced lung disease in rheumatoid arthritis: critical review of patterns
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009

Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests
Source: Eur Respir J 2002; 20: Suppl. 38, 106s
Year: 2002

Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Altered exhaled NO parameters in rheumatoid arthritis
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017

Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008